Expression of chemokines and chemokine receptors in cutaneous CD30+ lymphoproliferative disorders

British Journal of Dermatology

Volumn 154, Issue 5, 2006, Pages 904-909

  Yamaguchi, T ^a   Ohshima, K ^a   Karube, K ^a   Kawano, R ^a   Nakayama, J ^a   Suzumiya, J ^a   Kikuchi, M ^a  

^a FUKUOKA UNIVERSITY   (Japan)

Author keywords

Chemokine receptors; Chemokine chemokine receptor interactions; Lymphoma cell homing; Lymphomatoid papulosis; Primary cutaneous anaplastic large cell lymphoma

Indexed keywords

CD15 ANTIGEN; CD19 ANTIGEN; CD2 ANTIGEN; CD20 ANTIGEN; CD3 ANTIGEN; CD30 ANTIGEN; CD4 ANTIGEN; CD45RO ANTIGEN; CD5 ANTIGEN; CD8 ANTIGEN; CHEMOKINE; CHEMOKINE RECEPTOR; CHEMOKINE RECEPTOR CCR3; CHEMOKINE RECEPTOR CCR4; CHEMOKINE RECEPTOR CXCR3; MONOCLONAL ANTIBODY; RANTES; THYMUS AND ACTIVATION REGULATED CHEMOKINE;

ANTIGEN EXPRESSION; ARTICLE; CONTROLLED STUDY; CUTANEOUS T CELL LYMPHOMA; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; LARGE CELL LYMPHOMA; LYMPHOCYTE HOMING; LYMPHOID CELL; LYMPHOMA CELL; LYMPHOMATOID PAPULOSIS; NONHODGKIN LYMPHOMA; PRIMARY CUTANEOUS ANAPLASTIC LARGE CELL LYMPHOMA; PRIORITY JOURNAL; PROTEIN EXPRESSION; TISSUE SECTION;

ADOLESCENT; ADULT; ANTIGENS, CD30; CHEMOKINES; CHEMOKINES, CXC; CHILD; FEMALE; HUMANS; LIGANDS; LYMPHOMA, LARGE-CELL, KI-1; LYMPHOMATOID PAPULOSIS; MALE; MIDDLE AGED; NEOPLASM PROTEINS; RANTES; RECEPTORS, CHEMOKINE; SKIN NEOPLASMS;

EID: 33645802840     PISSN: 00070963     EISSN: 13652133     Source Type: Journal    
DOI: 10.1111/j.1365-2133.2005.07039.x     Document Type: Article

References (18)

1. Willemze R Kerl H Sterry W et al. EORTC classification for primary cutaneous lymphomas: a proposal from the Cutaneous Lymphoma Study Group of the European Organization for Research and Treatment of Cancer. Blood 1997 90 354 71.
2. Shabrawi-Caelen LE Kerl H Cerroni L. Lymphomatoid papulosis: reappraisal of clinicopathologic presentation and classification into subtypes A, B, and C. Arch Dermatol 2004 140 441 7.
3. Syrbe U Siverke J Hamann A. Th1/Th1 subsets: distinct differences in homing and chemokine receptor expression? Springer Semin Immunopathol 1999 21 263 85.
4. Mosmann TR Cherwinski H Bond MW et al. Two types of murine helper T cell clone. I. Definition according to profiles of lymphokine activities and secreted proteins. J Immunol 1986 136 2348 57.
5. Mosmann TR Coffman RL. TH1 and TH2 cells: different patterns of lymphokine secretion lead to different functional properties. Annu Rev Immunol 1989 7 145 73.
6. Jones D O'Hara C Kraus MD et al. Expression pattern of T-cell-associated chemokine receptors and their chemokines correlates with specific subtypes of T-cell non-Hodgkin lymphoma. Blood 2000 93 685 90.
7. Salusto F Lanzavecchia A Mackay CR. Chemokine and chemokine receptors in T cell priming and Th1/Th2-mediated responses. Immunol Today 1998 19 568 74.
8. D'Ambrosio D Iellem A Bonecchi R et al. Selective up-regulation of chemokine receptors CCR4 and CCR8 upon activation of polarized human type 2 Th cells. J Immunol 1998 161 5111 5.
9. Kleinhans M Tun-Kyi A Gilliet M et al. Functional expression of the eotaxin receptor CCR3 in CD30+ cutaneous T-cell lymphoma. Blood 2003 101 1487 93.
10. Lu D Duvic M Medeiros LJ et al. The T-cell chemokine receptor CXCR3 is expressed highly in low-grade mycosis fungoides. Hematopathology in low-grade mycosis fungoides. Hematopathology 2001 115 413 21.
11. Campbell JJ Haraldsen G Pan J et al. The chemokine receptor CCR4 in vascular recognition in cutaneous but not interstitial memory T cell. Nature 1999 400 776 80.
12. Vermeer MH Dukers DF ten Berge RL et al. Differential expression of thymus and activation regulated chemokine and its receptor CCR4 in nodal and cutaneous anaplastic large-cell lymphomas and Hodgkin's disease. Mod Pathol 2002 15 838 44.
13. Yagi H Tokura Y Furukawa F Takigawa M. Th2 cytokine mRNA expression in primary cutaneous CD30-positive lymphoproliferative disorders: successful treatment with recombinant interferon-γ. J Invest Dermatol 1996 107 827 32.
14. Luster AD Ravetch JV. Biochemical characterization of a gamma interferon-inducible cytokine (IP-10). J Exp Med 1987 166 1084 97.
15. Boorsma DM Flier J van den Brink EN et al. IP-10 mRNA expression in cultured keratinocytes is suppressed by inhibition of protein kinase-C and tyrosine kinase and elevation of cAMP. Cytokine 1999 11 469 75.
16. Tensen CP Vermeer MH van der Stoop PM et al. Epidermal interferon-gamma induced protein-10 (IP-10) and monokine induced by gamma-interferon (MIG) but not IL-8 mRNA expression is associated with epidermotropism in cutaneous T cell lymphoma. J Invest Dermatol 1998 111 222 6.
17. Tensen CP Flier J van der Raaij-Helmer EM et al. Human IP-9: a keratinocyte-derived high affinity CXC-chemokine ligand for the IP-10/MIG receptor (CXCR3). J Invest Dermatol 1999 112 716 22.
18. Sarris AH Daliani D Ulmer R et al. Interferon-inducible protein 10 and the pathogenesis of cutaneous T-cell lymphomas. Clin Cancer Res 1997 3 169 77.